PortfoliosLab logo
QGEN vs. DLB
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between QGEN and DLB is 0.49, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Performance

QGEN vs. DLB - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Qiagen N.V. (QGEN) and Dolby Laboratories, Inc. (DLB). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

QGEN:

-0.10

DLB:

-0.18

Sortino Ratio

QGEN:

-0.19

DLB:

-0.19

Omega Ratio

QGEN:

0.98

DLB:

0.98

Calmar Ratio

QGEN:

-0.20

DLB:

-0.21

Martin Ratio

QGEN:

-0.69

DLB:

-0.83

Ulcer Index

QGEN:

9.60%

DLB:

8.47%

Daily Std Dev

QGEN:

26.14%

DLB:

28.86%

Max Drawdown

QGEN:

-92.14%

DLB:

-62.19%

Current Drawdown

QGEN:

-26.49%

DLB:

-23.54%

Fundamentals

Market Cap

QGEN:

$9.16B

DLB:

$7.26B

EPS

QGEN:

$0.43

DLB:

$2.64

PE Ratio

QGEN:

98.42

DLB:

28.63

PEG Ratio

QGEN:

0.96

DLB:

2.08

PS Ratio

QGEN:

4.58

DLB:

5.50

PB Ratio

QGEN:

2.69

DLB:

2.83

Total Revenue (TTM)

QGEN:

$2.00B

DLB:

$1.32B

Gross Profit (TTM)

QGEN:

$1.00B

DLB:

$1.17B

EBITDA (TTM)

QGEN:

$372.10M

DLB:

$121.80M

Returns By Period

In the year-to-date period, QGEN achieves a -5.63% return, which is significantly lower than DLB's -3.61% return. Over the past 10 years, QGEN has underperformed DLB with an annualized return of 5.39%, while DLB has yielded a comparatively higher 8.02% annualized return.


QGEN

YTD

-5.63%

1M

-0.64%

6M

-1.77%

1Y

-2.66%

3Y*

-2.70%

5Y*

-0.49%

10Y*

5.39%

DLB

YTD

-3.61%

1M

1.61%

6M

-6.15%

1Y

-5.16%

3Y*

1.82%

5Y*

6.31%

10Y*

8.02%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Qiagen N.V.

Dolby Laboratories, Inc.

Risk-Adjusted Performance

QGEN vs. DLB — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

QGEN
The Risk-Adjusted Performance Rank of QGEN is 3737
Overall Rank
The Sharpe Ratio Rank of QGEN is 4646
Sharpe Ratio Rank
The Sortino Ratio Rank of QGEN is 3131
Sortino Ratio Rank
The Omega Ratio Rank of QGEN is 3232
Omega Ratio Rank
The Calmar Ratio Rank of QGEN is 4040
Calmar Ratio Rank
The Martin Ratio Rank of QGEN is 3737
Martin Ratio Rank

DLB
The Risk-Adjusted Performance Rank of DLB is 3535
Overall Rank
The Sharpe Ratio Rank of DLB is 4242
Sharpe Ratio Rank
The Sortino Ratio Rank of DLB is 3232
Sortino Ratio Rank
The Omega Ratio Rank of DLB is 3232
Omega Ratio Rank
The Calmar Ratio Rank of DLB is 3838
Calmar Ratio Rank
The Martin Ratio Rank of DLB is 3333
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

QGEN vs. DLB - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Qiagen N.V. (QGEN) and Dolby Laboratories, Inc. (DLB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current QGEN Sharpe Ratio is -0.10, which is higher than the DLB Sharpe Ratio of -0.18. The chart below compares the historical Sharpe Ratios of QGEN and DLB, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Dividends

QGEN vs. DLB - Dividend Comparison

QGEN's dividend yield for the trailing twelve months is around 3.00%, more than DLB's 1.73% yield.


TTM20242023202220212020201920182017201620152014
QGEN
Qiagen N.V.
3.00%2.88%0.00%0.00%0.00%0.00%0.00%0.00%3.42%0.00%0.00%0.00%
DLB
Dolby Laboratories, Inc.
1.73%1.57%1.29%1.45%0.96%0.91%1.15%1.08%0.94%1.11%1.25%0.23%

Drawdowns

QGEN vs. DLB - Drawdown Comparison

The maximum QGEN drawdown since its inception was -92.14%, which is greater than DLB's maximum drawdown of -62.19%. Use the drawdown chart below to compare losses from any high point for QGEN and DLB. For additional features, visit the drawdowns tool.


Loading data...

Volatility

QGEN vs. DLB - Volatility Comparison

Qiagen N.V. (QGEN) has a higher volatility of 6.77% compared to Dolby Laboratories, Inc. (DLB) at 5.15%. This indicates that QGEN's price experiences larger fluctuations and is considered to be riskier than DLB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

QGEN vs. DLB - Financials Comparison

This section allows you to compare key financial metrics between Qiagen N.V. and Dolby Laboratories, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


200.00M300.00M400.00M500.00M600.00M20212022202320242025
483.46M
369.56M
(QGEN) Total Revenue
(DLB) Total Revenue
Values in USD except per share items

QGEN vs. DLB - Profitability Comparison

The chart below illustrates the profitability comparison between Qiagen N.V. and Dolby Laboratories, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%20.0%40.0%60.0%80.0%100.0%20212022202320242025
63.9%
90.3%
(QGEN) Gross Margin
(DLB) Gross Margin
QGEN - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Qiagen N.V. reported a gross profit of 308.68M and revenue of 483.46M. Therefore, the gross margin over that period was 63.9%.

DLB - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Dolby Laboratories, Inc. reported a gross profit of 333.72M and revenue of 369.56M. Therefore, the gross margin over that period was 90.3%.

QGEN - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Qiagen N.V. reported an operating income of 115.35M and revenue of 483.46M, resulting in an operating margin of 23.9%.

DLB - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Dolby Laboratories, Inc. reported an operating income of 111.97M and revenue of 369.56M, resulting in an operating margin of 30.3%.

QGEN - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Qiagen N.V. reported a net income of 90.76M and revenue of 483.46M, resulting in a net margin of 18.8%.

DLB - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Dolby Laboratories, Inc. reported a net income of 91.79M and revenue of 369.56M, resulting in a net margin of 24.8%.